Humana (HUM) Tops Q3 EPS by 13c, Raises FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Humana (HUM) PT Lowered to $290 at BMO Capital on 3Q Report; 'Increased Competition in Medicare'
November 10, 2017 10:04 AM ESTBMO Capital lowered its price target on Humana (NYSE: HUM) to $290.00 (from $300.00) while maintaining a Outperform rating, following the company's third quarter earnings report.
Analyst Matt Borsch notes a reduced price target on the shares due to a lower than expected initial outlook... More
